Evidence map›Paper›PMID 32373616›Full record

ArticleFrontiers in medicine2020

Editorial: Pulmonary Hypertension: Mechanisms and Management, History and Future.

A A Roger Thompson, Martin R Wilkins, Jim M Wild, David G Kiely, Allan Lawrie

Abstract readEditorial
In one paragraph

Article in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

A A Roger ThompsonDepartment of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
Martin R WilkinsDepartment of Medicine and National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Jim M WildDepartment of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
David G KielyDepartment of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
Allan LawrieDepartment of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.

Funding

British Heart Foundation FS/13/48/30453British Heart Foundation SP/14/6/31350Medical Research Council MR/M008894/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersheart failureimagingpulmonary hypertensionscreening toolstherapeutics

Identifiers

PMID32373616
PMCPMC7186409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.